Johnson & Johnson (JNJ)
Johnson & Johnson - U.S. FDA approval of INLEXZO™(gemcitabine intravesical system) set to transform how certain bladder cancers are treated
Bio-Rad Laboratories Inc. (BIO)
DexCom Inc (DXCM)
Johnson & Johnson (JNJ)
U.S. FDA approval of INLEXZO™ (gemcitabine intravesical system) set to transform how certain bladder cancers are treated
Precipio Inc (PRPO)
Certara Inc (CERT)
Mind Technology Inc (MIND)
MIND TECHNOLOGY, INC. REPORTS FISCAL 2026 SECOND QUARTER RESULTS
Insulet Corporation (PODD)
bioAffinity Technologies Inc. (BIAFW)
Neuroone Medical Technologies Corp (NMTC)
Brookdale Senior Living Inc (BKD)
Brookdale Senior Living Inc. - Brookdale Reports August 2025 Occupancy